- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04866823
Meals for Moms: Medically-Tailored Meals for Women Who Had Gestational Diabetes
April 25, 2025 updated by: Wake Forest University Health Sciences
Meals for Moms: A Postpartum Medically-Tailored Meal Program to Promote Weight Loss and Blood Glucose Control Among Women With Hyperglycemia in Pregnancy
The purpose of this research study is to test whether delivery of medically tailored meals (meals designed specifically to be healthy) can be used to help reduce high blood sugar after delivery of a baby.
Participants will be recruited and consented during the third trimester of pregnancy but will begin study activities after delivery.
Participants will complete a series of questionnaires on demographics, health history, home environment, overall and financial stress, plans for weight loss and infant feeding, and food insecurity.
Participants will also be asked to wear continuous glucose monitors for two separate 14-day periods (within 2 weeks of delivery and at 3 months).
All participants will receive weekly emails with educational videos and 3 virtual visits with a member of the study team and will also be randomly assigned to an intervention or comparison group.
In the intervention, participants will receive weekly meal deliveries of 10 pre-prepared meals from Providence Community Kitchen (local company in Winston-Salem, NC) that are calorically restricted and appropriate for post-partum women with a history of gestational diabetes and who may be breast-feeding.
Women in the control condition will receive written resources on self-care, nutrition, and physical activity appropriate for post-partum women who had gestational diabetes.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Pregnancy and delivery can function as a "stress test" for future development of cardiovascular disease and metabolic disorders, with gestational diabetes and excessive weight gain during pregnancy leading to worse outcomes later in a mother's life.
The prevalence of both conditions continues to increase with the obesity epidemic, highlighting the urgent need for successful interventions to reverse maternal weight gain and promote normal blood sugars.
The early postpartum period provides a critical opportunity to address diet behaviors that are related to both weight and diabetes.
Postpartum medically-tailored meal delivery is a novel approach that may allow for improved blood sugar control and weight loss in a traditionally hard-to-engage patient population.
There is currently no available data on the cost, feasibility, or effectiveness of providing medically-tailored meals to postpartum women.
This is a pilot study of medically-tailored meals for new mothers whose pregnancies were complicated by gestational diabetes, and whose total gestational weight gain exceeded recommendations.
Study will enroll 30 women with gestational diabetes and excessive gestational weight gain late in the third trimester of a singleton pregnancy.
Data collection and intervention activities will begin after delivery.
All participants will wear a continuous glucose monitor for baseline (first 2 weeks after delivery) and at follow up (after 3 months).
Participants will also completed self-administered questionnaires, receive weekly informational videos by email, and have 3 monthly in-person check-ins with a member of the study team.
Twenty participants will be randomly assigned to a medically-tailored meals intervention and 10 to a usual-care comparison group.
A local community-based program will prepare and deliver 10 medically-tailored meals per week to intervention participants for their first 3 months postpartum.
Study Type
Interventional
Enrollment (Actual)
12
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Winston-Salem, North Carolina, United States, 27101
- Wake Forest Baptist Health
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Demographics: Women 18 years of age and older who reside in Forsyth County, NC
- Pregnancy: Currently 24 or more weeks into a singleton pregnancy
- Clinical evidence of gestational diabetes mellitus (GDM) defined as either 3-hour oral glucose tolerance test (OGTT) results obtained in the second trimester of pregnancy that show at least 2 abnormal values or a diagnosis of "gestational diabetes" included on the Problem List in medical record during current pregnancy, regardless of OGTT values
- Excessive gestational weight gain: Most recent weight exceeds predicted weight gain for current weeks gestational age defined as pre-pregnancy Body mass index (BMI) of 30 kg/m2 or more and weight at most recent clinical visit 20+ pounds over pre-pregnancy weight or pre-pregnancy BMI of 25-29.9 kg/m2 and weight at most recent clinical visit 25+ pounds over pre-pregnancy weight
- English Proficiency: Able to read/understand English at or above a level sufficient to comprehend recruitment, informed consent, and intervention materials.
- Access to a smart phone/tablet/computer capable of connecting to video calls or teleconferencing software.
- Willingness to Accept Randomization: Prospective participants must be willing to accept randomization to either the medically tailored meal intervention or the comparison intervention condition.
Exclusion Criteria:
- Clinical history of diabetes (type 1 or 2) pre-pregnancy
- Non-singleton pregnancy
- Other chronic diseases or medical conditions that would increase risk or make participation otherwise unsafe, including special dietary needs. A clinician investigator will review the medical record for all potential participants to determine if any such conditions exist.
- Known food allergies of sensitivities. Potential participants who report special dietary requirements including vegetarians, vegans, those who follow kosher or other specialized diets will be excluded due to the small nature of this pilot study.
- History of allergic skin reaction to adhesive tape
- Unable or unwilling to wear a continuous glucose monitor (CGM) device
- Is scheduled for an MRI during the study weeks, making use of the CGM device unsafe
- Other: Conditions/criteria likely to interfere with participation and acceptance of randomized assignment, including the following: inability/unwillingness to give informed consent, major psychiatric or cognitive problems (schizophrenia, dementia, self-reported substance or alcohol abuse), participation in another research study that would interfere with Meals for Moms
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Medically Tailored Meals
A series of medically tailored meals appropriate for women with gestational diabetes will be developed in partnership with chefs from a local community kitchen and catering company.
Meals will create a slight caloric deficit in order to promote gradual weight loss, but with sufficient energy intake and macronutrient balance to allow breastfeeding.
These meals will be roughly 40% carbohydrate, 30% protein, and 30% fat in composition.
Study Team will plan up to 20 unique lunch and dinner meals for the series.
Each meal will be prepared to be between 450-600 kcal and to contain 6 ounces of protein, 4 ounces of vegetable and I cup of whole grain (at a minimum).
Participants will receive detailed recipe cards and nutrition information with each meal.
In addition to receiving the medically tailored meals, participants will be advised to supplement their own breakfast +/- snacks to reach a total daily calorie goal determined by starting BMI category.
|
Participants will receive weekly meals (20 per week) prepared by a local community kitchen and catering group.
Each week, 10 dinners and 10 lunches will be delivered to the participant's home with instructions for storage, re-heating, recipes, and nutritional information.
|
|
No Intervention: Usual Care Comparison Group
Participants in this group will receive written materials on self-care, nutrition, and physical activity in the postpartum period and community resources for healthy living.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Days of Continuous Glucose Monitoring in Postpartum Mothers
Time Frame: 3 months
|
Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at 3 months.
|
3 months
|
|
Number of Meals Successfully Ordered and Delivered
Time Frame: 3 months
|
Determine the percent of meals successfully ordered & delivered in the intervention group
|
3 months
|
|
Number of Dollars Cost
Time Frame: 3 months
|
Determine the total cost across all participants for the medically tailored meal program per participant assuming 20 meals per week provided to each participant for 12 weeks.
|
3 months
|
|
Days of Continuous Glucose Monitoring in Postpartum Mothers
Time Frame: 14 day period assessed at baseline
|
Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at baseline.
|
14 day period assessed at baseline
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Mean Glucose
Time Frame: Baseline and month 3
|
Using data from the continuous glucose monitor, changes in mean glucose will be assessed
|
Baseline and month 3
|
|
Change in Glucose Management Indicator (GMI)
Time Frame: Baseline and month 3
|
Using data from the continuous glucose monitor, changes in GMI will be assessed as a proxy measure of hemoglobin A1c
|
Baseline and month 3
|
|
Change in Glycemic Variability
Time Frame: Baseline and month 3
|
Using data from the continuous glucose monitor, changes in glycemic variability (percent coefficient of variation) will be assessed
|
Baseline and month 3
|
|
Change in Time in Range (TIR)
Time Frame: Baseline and month 3
|
Using data from the continuous glucose monitor, changes in percent of time in range (70 mg/dL to 180 mg/dL) will be assessed
|
Baseline and month 3
|
|
Change in Time Above Range (Hyperglycemia)
Time Frame: Baseline and month 3
|
Using data from the continuous glucose monitor, changes in percent of time above the target range (70 mg/dL to 180 mg/dL) will be assessed
|
Baseline and month 3
|
|
Change in Time Below Range (Hypoglycemia)
Time Frame: Baseline and month 3
|
Using data from the continuous glucose monitor, changes in percent of time below the target range (70 mg/dL to 180 mg/dL) will be assessed
|
Baseline and month 3
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Morgana Mongraw-Chaffin, Wake Forest University Health Sciences
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 20, 2021
Primary Completion (Actual)
January 17, 2023
Study Completion (Actual)
January 17, 2023
Study Registration Dates
First Submitted
April 26, 2021
First Submitted That Met QC Criteria
April 26, 2021
First Posted (Actual)
April 30, 2021
Study Record Updates
Last Update Posted (Actual)
April 29, 2025
Last Update Submitted That Met QC Criteria
April 25, 2025
Last Verified
February 1, 2023
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB00072715
- 40010554 (Other Identifier: National Institute of Diabetes and Digestive and Kidney Diseases)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diabetes, Gestational
-
IRCCS Burlo GarofoloCompletedGestational Diabetes | Gestational Diabetes Mellitus | Pregnancy-Induced Diabetes | Diabetes Mellitus, Gestational | Diabetes, Pregnancy InducedIsrael, Italy, Netherlands, Slovenia, Sri Lanka
-
UPECLIN HC FM Botucatu UnespCompletedGestational Diabetes Mellitus | Pregestational Diabetes Mellitus | Mild Gestational HyperglycemiaBrazil
-
Royal College of Surgeons, IrelandHealth Research Board - Trials Methodology Research NetworkCompletedPre-Gestational DiabetesIreland
-
University of Texas Southwestern Medical CenterCompletedMild Gestational DiabetesUnited States
-
University of Colorado, DenverKaiser PermanenteCompletedGestational Diabetes MellitusUnited States
-
Intermountain Health Care, Inc.Withdrawn
-
University of Tennessee Graduate School of MedicineRecruitingInsulin Resistance | Pregnancy Complications | Pregnancy | Preeclampsia | Gestational Diabetes | Gestational Diabetes Mellitus in Pregnancy | Placental Dysfunction | Gestational Diabetes Mellitus (GDM) | Preeclampsia (PE) | Cardiometabolic Diseases | Gestational Complications | Preeclampsia (PE) RiskUnited States
-
Woman'sBaton Rouge Area FoundationCompletedGestational Diabetes MellitusUnited States
-
Lahore University of Biological and Applied SciencesNot yet recruitingPregnancy Complications | Gestational Diabetes Mellitus (GDM) | Diabetes During Pregnancy | Pregnancy in Diabetes | Gestational | Diabetes ComplicationPakistan
-
Baylor College of MedicineRecruitingGestational Diabetes MellitusUnited States
Clinical Trials on Medically Tailored Meals
-
University of PennsylvaniaAmerican Heart AssociationEnrolling by invitation
-
Kaiser PermanenteCompletedLiver Failure | Heart Failure | Diabetes Mellitus | Cancer | End Stage Renal Disease | CopdUnited States
-
Kaiser PermanenteCompletedHeart Failure | Diabetes Mellitus, Type 2 | Chronic Kidney DiseasesUnited States
-
Thomas Jefferson UniversityCompletedHeart FailureUnited States
-
Amanda ShallcrossAmerican Heart AssociationCompletedHypertension | Obesity | Metabolic Syndrome | Type2diabetesUnited States
-
University of California, San DiegoStanford UniversityCompletedHeart Diseases | Heart Failure | Heart Failure,CongestiveUnited States
-
Drexel UniversityChildren's Hospital of PhiladelphiaNot yet recruiting
-
University of Texas at AustinMeals on Wheels Central TexasEnrolling by invitationDiabetesUnited States
-
UNC Lineberger Comprehensive Cancer CenterNational Institute of Nursing Research (NINR)Recruiting
-
University of Texas Southwestern Medical CenterAmerican Heart AssociationCompletedHeart FailureUnited States